Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii

15 Sept 2021

Abstract excerpt

The evidence that antibiotic heteroresistance is responsible for treatment failure in clinical settings is increasing. Thus, detection and characterization of heteroresistance would be important for appropriate therapeutic guidance to treat bacterial infections.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Burkholderia infections and melioidosis
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34523993
DOI: 10.1128/spectrum.01010-21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumanniiPMID 34523993Read ↗

Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatmentSemantic proximity Read ↗

Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, ChinaSemantic proximity Read ↗

What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?Semantic proximity Read ↗

Investigation of colistin heteroresistance in multidrug-resistant Acinetobacter baumannii clinical isolatesSemantic proximity Read ↗

Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii StrainsSemantic proximity Read ↗

Acinetobacter baumannii: an evolving and cunning opponentSemantic proximity Read ↗

Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.Semantic proximity Read ↗

Bacterial heteroresistance mechanisms, dynamics, and emerging diagnostic approaches.Semantic proximity Read ↗

Resistance associated genomic variations for moderate level tigecycline resistance evolution in Acinetobacter baumannii.Semantic proximity Read ↗

Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.Semantic proximity Read ↗

Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern IranSemantic proximity Read ↗

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.